Article Information
History
- August 21, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Dimitrios C. Mastellos1,§,
- Bruno G. P. Pires da Silva2,§,
- Benedito A. L. Fonseca3,
- Natasha P. Fonseca2,
- Maria A. Martins4,
- Sara Mastaglio5,
- Annalisa Ruggeri5,
- Marina Sironi6,
- Peter Radermacher7,
- Panagiotis Skendros8,
- Konstantinos Ritis8,
- Ilenia Manfra9,
- Simona Iacobelli10,
- Markus Huber-Lang11,
- Bo Nilsson12,
- Despina Yancopoulou13,
- E. Sander Connolly14,
- Cecilia Garlanda6,15,
- Fabio Ciceri5,16,
- Antonio M. Risitano9,17,
- Rodrigo T. Calado2 and
- John D. Lambris18,*
- 1National Center for Scientific Research ‘Demokritos’, Aghia Paraskevi, Athens, Greece
- 2Department of Medical Imaging, Hematology and Clinical Oncology, University of São Paulo, Ribeirão Preto School of Medicine, Brazil
- 3Department of Internal Medicine, University of São Paulo, Ribeirão Preto School of Medicine, Brazil
- 4Intensive Care Unit, University Hospital, University of São Paulo, Ribeirão Preto School of Medicine, Brazil
- 5Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
- 6Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy
- 7Sektion Anästhesiologische Pathophysiologie und Verfahrensentwicklung, University Hospital of Ulm, Ulm, Germany
- 8First Department of Internal Medicine and Laboratory of Molecular Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece
- 9AORN San Giuseppe Moscati, Hematology and Hematopoietic Stem Cell Transplantation Unit, Avellino, Italy
- 10Department of Biology, University of Rome Tor Vergata, Rome, Italy
- 11Institute for Clinical and Experimental Trauma-Immunology, University Hospital of Ulm, Ulm, Germany
- 12Division of Clinical Immunology, Uppsala University Hospital, Uppsala, Sweden
- 13Amyndas Pharmaceuticals, Glyfada, Greece
- 14Department of Neurological Surgery, Columbia University, New York, NY, USA
- 15Humanitas University, Pieve Emanuele, Milan, Italy
- 16University Vita Salute San Raffaele, Milan, Italy
- 17Federico II University of Naples, Naples, Italy
- 18Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- ↵*corresponding author, lambris{at}pennmedicine.upenn.edu (JDL)
↵§ these authors contributed equally
Posted August 21, 2020.
Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy
